Last reviewed · How we verify
Prevention of pulmonary embolism
Approved treatments
- Xarelto · University Hospital, Montpellier
- Xarelto · Johnson & Johnson
Selective FXa inhibitor that decreases thrombin generation without requiring cofactors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of pulmonary embolism patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of pulmonary embolism treatment landscape brief
- Prevention of pulmonary embolism treatment updates RSS
Frequently asked questions about Prevention of pulmonary embolism
What drugs treat Prevention of pulmonary embolism?
Tracked treatments include Xarelto.
What is the treatment for Prevention of pulmonary embolism?
Standard treatment for Prevention of pulmonary embolism includes Xarelto. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of pulmonary embolism patent cliff · Prevention of pulmonary embolism CI report
- Treatment: Xarelto · University Hospital, Montpellier
- Treatment: Xarelto · Johnson & Johnson
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing